Una Software, the AI-powered FP&A software built for the pace of modern business, today announced it has closed its seed financing, bringing total funding raised to $13 million. The company also ...

Dexcom, Inc. , the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take ...

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from ...

Woori IO plans to accelerate its noninvasive CGM launch after FDA announced relaxed wearable device regulations.

Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.

Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the ...

Better late than never, right? Look, we know it’s late January. Most people have already abandoned their New Year’s resolutions, and the wearables world is already whispering about what’s coming later ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and your fit-fluencer friend. Jake Leach, who took over as Dexcom CEO today, wants ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and Bernstein lowered their price targets on the stock, citing concerns over the ...

Mr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44th annual J.P. Morgan Healthcare Conference A completely reimagined Stelo app experience will launch this ...

AI-powered medical wearables and software are flourishing following the FDA’s new hands-off regulatory guidance.